Symbol:
Lig3
Name:
DNA ligase 3
RGD ID:
1309875
Description:
Enables DNA ligase activity. Predicted to be involved in DNA metabolic process; mitochondrion organization; and negative regulation of mitochondrial DNA replication. Predicted to act upstream of or within double-strand break repair via nonhomologous end joining; mitochondrial DNA repair; and negative regulation of DNA recombination. Predicted to be located in nucleoplasm and synaptonemal complex. Predicted to be part of DNA ligase III-XRCC1 complex. Predicted to be active in mitochondrion and nucleus. Biomarker of middle cerebral artery infarction. Human ortholog(s) of this gene implicated in mitochondrial DNA depletion syndrome 20 and pancreatic cancer. Orthologous to human LIG3 (DNA ligase 3); PARTICIPATES IN nucleotide excision repair pathway; base excision repair pathway; INTERACTS WITH 2,3,7,8-tetrachlorodibenzodioxine; 2,6-dinitrotoluene; 4-hydroperoxycyclophosphamide.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
DNA ligase (ATP) 3; ligase III, DNA, ATP-dependent; LOC303369
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
LIG3 (DNA ligase 3)
HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, Panther, PhylomeDB
Mus musculus (house mouse):
Lig3 (ligase III, DNA, ATP-dependent)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chinchilla lanigera (long-tailed chinchilla):
Lig3 (DNA ligase 3)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
LIG3 (DNA ligase 3)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
LIG3 (DNA ligase 3)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Lig3 (DNA ligase 3)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
LIG3 (DNA ligase 3)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (green monkey):
LIG3 (DNA ligase 3)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Lig3 (DNA ligase 3)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Other homologs 2
Homo sapiens (human):
ADPRH (ADP-ribosylarginine hydrolase)
HGNC
OMA
Alliance orthologs 3
Homo sapiens (human):
LIG3 (DNA ligase 3)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Mus musculus (house mouse):
Lig3 (ligase III, DNA, ATP-dependent)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
lig3 (ligase III, DNA, ATP-dependent)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Caenorhabditis elegans (roundworm):
K07C5.3
Alliance
DIOPT (Ensembl Compara|Hieranoid|OrthoFinder)
Drosophila melanogaster (fruit fly):
DNAlig3
Alliance
DIOPT (Ensembl Compara|InParanoid|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Caenorhabditis elegans (roundworm):
Y73B6BL.14
Alliance
DIOPT (Ensembl Compara|OrthoFinder|PhylomeDB)
Xenopus tropicalis (tropical clawed frog):
lig3
Alliance
DIOPT (Ensembl Compara|OMA|OrthoFinder|PANTHER|PhylomeDB)
Candidate Gene For:
Bp301
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 10 68,215,371 - 68,238,705 (+) NCBI GRCr8 mRatBN7.2 10 67,717,808 - 67,741,141 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 10 67,717,812 - 67,798,414 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 10 72,337,877 - 72,361,210 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 10 71,843,252 - 71,866,586 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 10 67,305,075 - 67,328,397 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 10 70,134,734 - 70,158,051 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 10 70,134,729 - 70,158,055 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 10 69,765,441 - 69,788,758 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 10 71,000,287 - 71,021,398 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 10 71,013,909 - 71,035,020 (+) NCBI Celera 10 66,662,184 - 66,683,295 (+) NCBI Celera Cytogenetic Map 10 q26 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Lig3 Rat (-)-epigallocatechin 3-gallate multiple interactions ISO LIG3 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of LIG3 mRNA CTD PMID:22079256 Lig3 Rat 17alpha-ethynylestradiol multiple interactions ISO Lig3 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LIG3 mRNA CTD PMID:17942748 Lig3 Rat 17beta-estradiol increases expression ISO Lig3 (Mus musculus) 6480464 Estradiol results in increased expression of LIG3 mRNA CTD PMID:39298647 Lig3 Rat 1H-pyrazole increases expression ISO Lig3 (Mus musculus) 6480464 pyrazole results in increased expression of LIG3 mRNA CTD PMID:17945193 Lig3 Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Lig3 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LIG3 mRNA CTD PMID:17942748 Lig3 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO LIG3 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of LIG3 mRNA CTD PMID:20106945 and PMID:21632981 Lig3 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Lig3 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of LIG3 mRNA CTD PMID:21570461 Lig3 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of LIG3 mRNA CTD PMID:21215274 and PMID:33387578 Lig3 Rat 2,6-dinitrotoluene affects expression EXP 6480464 2 and 6-dinitrotoluene affects the expression of LIG3 mRNA CTD PMID:21346803 Lig3 Rat 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO LIG3 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of LIG3 mRNA CTD PMID:28628672 Lig3 Rat 4-hydroperoxycyclophosphamide decreases expression EXP 6480464 perfosfamide results in decreased expression of LIG3 mRNA CTD PMID:11754170 Lig3 Rat 4-hydroxyphenyl retinamide increases expression ISO Lig3 (Mus musculus) 6480464 Fenretinide results in increased expression of LIG3 mRNA CTD PMID:28973697 Lig3 Rat acrylamide decreases expression ISO LIG3 (Homo sapiens) 6480464 Acrylamide results in decreased expression of LIG3 mRNA CTD PMID:32763439 Lig3 Rat aflatoxin B1 increases expression ISO Lig3 (Mus musculus) 6480464 Aflatoxin B1 results in increased expression of LIG3 mRNA CTD PMID:19770486 Lig3 Rat aflatoxin B1 increases methylation ISO LIG3 (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of LIG3 intron CTD PMID:30157460 Lig3 Rat aristolochic acid A decreases expression ISO LIG3 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of LIG3 mRNA CTD PMID:33212167 Lig3 Rat arsane decreases expression ISO LIG3 (Homo sapiens) 6480464 Arsenic results in decreased expression of LIG3 mRNA and Arsenic results in decreased expression of LIG3 protein CTD PMID:21332098 Lig3 Rat arsane multiple interactions ISO LIG3 (Homo sapiens) 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LIG3 mRNA more ... CTD PMID:21332098 and PMID:39836092 Lig3 Rat arsenic atom decreases expression ISO LIG3 (Homo sapiens) 6480464 Arsenic results in decreased expression of LIG3 mRNA and Arsenic results in decreased expression of LIG3 protein CTD PMID:21332098 Lig3 Rat arsenic atom multiple interactions ISO LIG3 (Homo sapiens) 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LIG3 mRNA more ... CTD PMID:21332098 and PMID:39836092 Lig3 Rat benzo[a]pyrene affects methylation ISO LIG3 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of LIG3 promoter CTD PMID:27901495 Lig3 Rat benzo[a]pyrene diol epoxide I decreases expression ISO LIG3 (Homo sapiens) 6480464 7 more ... CTD PMID:34454013 Lig3 Rat bis(2-ethylhexyl) phthalate increases expression ISO LIG3 (Homo sapiens) 6480464 Diethylhexyl Phthalate results in increased expression of LIG3 mRNA CTD PMID:33120273 Lig3 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of LIG3 mRNA CTD PMID:25181051 Lig3 Rat bisphenol A decreases expression ISO LIG3 (Homo sapiens) 6480464 bisphenol A results in decreased expression of LIG3 mRNA and bisphenol A results in decreased expression of LIG3 protein CTD PMID:33376534 more ... Lig3 Rat bisphenol A multiple interactions ISO Lig3 (Mus musculus) 6480464 Melatonin inhibits the reaction [bisphenol A results in decreased expression of LIG3 mRNA] CTD PMID:36633214 Lig3 Rat bisphenol A multiple interactions ISO LIG3 (Homo sapiens) 6480464 Melatonin inhibits the reaction [bisphenol A results in decreased expression of LIG3 mRNA] CTD PMID:36633214 Lig3 Rat bisphenol A decreases expression ISO Lig3 (Mus musculus) 6480464 bisphenol A results in decreased expression of LIG3 mRNA CTD PMID:36633214 Lig3 Rat bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of LIG3 gene CTD PMID:28505145 Lig3 Rat bisphenol F multiple interactions ISO LIG3 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of LIG3 mRNA CTD PMID:28628672 Lig3 Rat C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of LIG3 mRNA CTD PMID:19167457 Lig3 Rat caffeine affects phosphorylation ISO LIG3 (Homo sapiens) 6480464 Caffeine affects the phosphorylation of LIG3 protein CTD PMID:35688186 Lig3 Rat carbon nanotube increases expression ISO Lig3 (Mus musculus) 6480464 Nanotubes and Carbon results in increased expression of LIG3 mRNA CTD PMID:25620056 Lig3 Rat CGP 52608 multiple interactions ISO LIG3 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to LIG3 gene] CTD PMID:28238834 Lig3 Rat chlorpyrifos increases expression ISO LIG3 (Homo sapiens) 6480464 Chlorpyrifos results in increased expression of LIG3 mRNA CTD PMID:28887667 Lig3 Rat chlorpyrifos decreases expression ISO Lig3 (Mus musculus) 6480464 Chlorpyrifos results in decreased expression of LIG3 mRNA CTD PMID:37019170 Lig3 Rat clofibrate multiple interactions ISO Lig3 (Mus musculus) 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of LIG3 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of LIG3 mRNA] CTD PMID:17585979 Lig3 Rat coumarin increases phosphorylation ISO LIG3 (Homo sapiens) 6480464 coumarin results in increased phosphorylation of LIG3 protein CTD PMID:35688186 Lig3 Rat curcumin multiple interactions ISO LIG3 (Homo sapiens) 6480464 Curcumin inhibits the reaction [Arsenic results in decreased expression of LIG3 mRNA] and Curcumin inhibits the reaction [Arsenic results in decreased expression of LIG3 protein] CTD PMID:21332098 Lig3 Rat cyclosporin A increases expression ISO LIG3 (Homo sapiens) 6480464 Cyclosporine results in increased expression of LIG3 mRNA CTD PMID:20106945 and PMID:25562108 Lig3 Rat dexamethasone multiple interactions ISO LIG3 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of LIG3 mRNA CTD PMID:28628672 Lig3 Rat Dibutyl phosphate affects expression ISO LIG3 (Homo sapiens) 6480464 di-n-butylphosphoric acid affects the expression of LIG3 mRNA CTD PMID:37042841 Lig3 Rat dibutyl phthalate decreases expression ISO LIG3 (Homo sapiens) 6480464 Dibutyl Phthalate results in decreased expression of LIG3 mRNA CTD PMID:33120273 Lig3 Rat dicrotophos increases expression ISO LIG3 (Homo sapiens) 6480464 dicrotophos results in increased expression of LIG3 mRNA CTD PMID:28302478 Lig3 Rat dorsomorphin multiple interactions ISO LIG3 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LIG3 mRNA CTD PMID:27188386 Lig3 Rat doxorubicin decreases expression ISO LIG3 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of LIG3 mRNA CTD PMID:29803840 Lig3 Rat entinostat decreases expression ISO LIG3 (Homo sapiens) 6480464 entinostat results in decreased expression of LIG3 mRNA CTD PMID:27188386 Lig3 Rat enzyme inhibitor multiple interactions ISO LIG3 (Homo sapiens) 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of LIG3 protein CTD PMID:23301498 Lig3 Rat epoxiconazole increases expression ISO Lig3 (Mus musculus) 6480464 epoxiconazole results in increased expression of LIG3 mRNA CTD PMID:35436446 Lig3 Rat ethyl methanesulfonate decreases expression ISO LIG3 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in decreased expression of LIG3 mRNA CTD PMID:23649840 Lig3 Rat formaldehyde decreases expression ISO LIG3 (Homo sapiens) 6480464 Formaldehyde results in decreased expression of LIG3 mRNA CTD PMID:23649840 Lig3 Rat FR900359 affects phosphorylation ISO LIG3 (Homo sapiens) 6480464 FR900359 affects the phosphorylation of LIG3 protein CTD PMID:37730182 Lig3 Rat genistein decreases expression ISO LIG3 (Homo sapiens) 6480464 Genistein results in decreased expression of LIG3 mRNA CTD PMID:15257099 Lig3 Rat glyphosate increases expression ISO LIG3 (Homo sapiens) 6480464 Glyphosate results in increased expression of LIG3 mRNA CTD PMID:31295307 Lig3 Rat indometacin multiple interactions ISO LIG3 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of LIG3 mRNA CTD PMID:28628672 Lig3 Rat iron atom decreases activity ISO LIG3 (Homo sapiens) 6480464 Iron results in decreased activity of LIG3 protein CTD PMID:20622253 Lig3 Rat iron(0) decreases activity ISO LIG3 (Homo sapiens) 6480464 Iron results in decreased activity of LIG3 protein CTD PMID:20622253 Lig3 Rat ivermectin decreases expression ISO LIG3 (Homo sapiens) 6480464 Ivermectin results in decreased expression of LIG3 protein CTD PMID:32959892 Lig3 Rat melatonin multiple interactions ISO LIG3 (Homo sapiens) 6480464 Melatonin inhibits the reaction [bisphenol A results in decreased expression of LIG3 mRNA] CTD PMID:36633214 Lig3 Rat melatonin multiple interactions ISO Lig3 (Mus musculus) 6480464 Melatonin inhibits the reaction [bisphenol A results in decreased expression of LIG3 mRNA] CTD PMID:36633214 Lig3 Rat methyl methanesulfonate decreases expression ISO LIG3 (Homo sapiens) 6480464 Methyl Methanesulfonate results in decreased expression of LIG3 mRNA CTD PMID:23649840 Lig3 Rat Methylazoxymethanol acetate affects expression EXP 6480464 Methylazoxymethanol Acetate affects the expression of LIG3 mRNA CTD PMID:28349193 Lig3 Rat miconazole increases expression EXP 6480464 Miconazole results in increased expression of LIG3 mRNA CTD PMID:22262564 Lig3 Rat monocrotophos increases expression ISO LIG3 (Homo sapiens) 6480464 Monocrotophos results in increased expression of LIG3 mRNA CTD PMID:28887667 Lig3 Rat N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine increases expression ISO LIG3 (Homo sapiens) 6480464 N more ... CTD PMID:33645215 Lig3 Rat paracetamol multiple interactions ISO Lig3 (Mus musculus) 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of LIG3 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of LIG3 mRNA] CTD PMID:17585979 Lig3 Rat paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of LIG3 mRNA CTD PMID:33387578 Lig3 Rat paracetamol decreases expression ISO LIG3 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of LIG3 mRNA CTD PMID:22230336 Lig3 Rat paracetamol affects expression ISO Lig3 (Mus musculus) 6480464 Acetaminophen affects the expression of LIG3 mRNA CTD PMID:17562736 Lig3 Rat perfluorooctane-1-sulfonic acid decreases expression ISO Lig3 (Mus musculus) 6480464 perfluorooctane sulfonic acid results in decreased expression of LIG3 protein CTD PMID:26178269 Lig3 Rat perfluorooctane-1-sulfonic acid multiple interactions ISO Lig3 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of LIG3 mRNA CTD PMID:36331819 Lig3 Rat pirinixic acid decreases expression ISO Lig3 (Mus musculus) 6480464 pirinixic acid results in decreased expression of LIG3 mRNA CTD PMID:18445702 Lig3 Rat potassium bromate decreases expression ISO LIG3 (Homo sapiens) 6480464 potassium bromate results in decreased expression of LIG3 mRNA CTD PMID:22539617 Lig3 Rat potassium chromate decreases expression ISO LIG3 (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of LIG3 mRNA CTD PMID:22079256 Lig3 Rat potassium chromate multiple interactions ISO LIG3 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of LIG3 mRNA CTD PMID:22079256 Lig3 Rat rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of LIG3 mRNA CTD PMID:19013527 Lig3 Rat SB 431542 multiple interactions ISO LIG3 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LIG3 mRNA CTD PMID:27188386 Lig3 Rat silver atom decreases expression ISO Lig3 (Mus musculus) 6480464 Silver results in decreased expression of LIG3 mRNA CTD PMID:27131904 Lig3 Rat silver(0) decreases expression ISO Lig3 (Mus musculus) 6480464 Silver results in decreased expression of LIG3 mRNA CTD PMID:27131904 Lig3 Rat sodium arsenite decreases expression ISO Lig3 (Mus musculus) 6480464 sodium arsenite results in decreased expression of LIG3 mRNA CTD PMID:20643705 Lig3 Rat sodium arsenite decreases expression ISO LIG3 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of LIG3 mRNA CTD PMID:38568856 Lig3 Rat sodium arsenite multiple interactions ISO LIG3 (Homo sapiens) 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LIG3 mRNA and sodium arsenite inhibits the reaction [Zinc binds to LIG3 protein] CTD PMID:36087615 and PMID:39836092 Lig3 Rat sodium arsenite increases expression ISO Lig3 (Mus musculus) 6480464 sodium arsenite results in increased expression of LIG3 mRNA CTD PMID:20643705 Lig3 Rat sodium dodecyl sulfate increases expression ISO LIG3 (Homo sapiens) 6480464 Sodium Dodecyl Sulfate results in increased expression of LIG3 mRNA CTD PMID:31734321 Lig3 Rat sodium fluoride increases expression ISO Lig3 (Mus musculus) 6480464 Sodium Fluoride results in increased expression of LIG3 mRNA CTD PMID:27862939 Lig3 Rat trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of LIG3 mRNA CTD PMID:33387578 Lig3 Rat trichostatin A affects expression ISO LIG3 (Homo sapiens) 6480464 trichostatin A affects the expression of LIG3 mRNA CTD PMID:28542535 Lig3 Rat trimellitic anhydride increases expression ISO Lig3 (Mus musculus) 6480464 trimellitic anhydride results in increased expression of LIG3 mRNA CTD PMID:19042947 Lig3 Rat valproic acid decreases methylation ISO LIG3 (Homo sapiens) 6480464 Valproic Acid results in decreased methylation of LIG3 gene CTD PMID:29154799 Lig3 Rat valproic acid decreases expression ISO LIG3 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of LIG3 mRNA CTD PMID:23179753 and PMID:28001369 Lig3 Rat valproic acid affects expression ISO LIG3 (Homo sapiens) 6480464 Valproic Acid affects the expression of LIG3 mRNA CTD PMID:25979313 Lig3 Rat valproic acid multiple interactions ISO LIG3 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LIG3 mRNA CTD PMID:27188386 Lig3 Rat zinc atom affects binding ISO LIG3 (Homo sapiens) 6480464 Zinc binds to LIG3 protein CTD PMID:36087615 Lig3 Rat zinc atom multiple interactions ISO LIG3 (Homo sapiens) 6480464 sodium arsenite inhibits the reaction [Zinc binds to LIG3 protein] CTD PMID:36087615 Lig3 Rat zinc(0) affects binding ISO LIG3 (Homo sapiens) 6480464 Zinc binds to LIG3 protein CTD PMID:36087615 Lig3 Rat zinc(0) multiple interactions ISO LIG3 (Homo sapiens) 6480464 sodium arsenite inhibits the reaction [Zinc binds to LIG3 protein] CTD PMID:36087615
Imported Annotations - KEGG (archival)
(-)-epigallocatechin 3-gallate (ISO) 17alpha-ethynylestradiol (ISO) 17beta-estradiol (ISO) 1H-pyrazole (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2,6-dinitrotoluene (EXP) 3-isobutyl-1-methyl-7H-xanthine (ISO) 4-hydroperoxycyclophosphamide (EXP) 4-hydroxyphenyl retinamide (ISO) acrylamide (ISO) aflatoxin B1 (ISO) aristolochic acid A (ISO) arsane (ISO) arsenic atom (ISO) benzo[a]pyrene (ISO) benzo[a]pyrene diol epoxide I (ISO) bis(2-ethylhexyl) phthalate (ISO) bisphenol A (EXP,ISO) bisphenol F (ISO) C60 fullerene (EXP) caffeine (ISO) carbon nanotube (ISO) CGP 52608 (ISO) chlorpyrifos (ISO) clofibrate (ISO) coumarin (ISO) curcumin (ISO) cyclosporin A (ISO) dexamethasone (ISO) Dibutyl phosphate (ISO) dibutyl phthalate (ISO) dicrotophos (ISO) dorsomorphin (ISO) doxorubicin (ISO) entinostat (ISO) enzyme inhibitor (ISO) epoxiconazole (ISO) ethyl methanesulfonate (ISO) formaldehyde (ISO) FR900359 (ISO) genistein (ISO) glyphosate (ISO) indometacin (ISO) iron atom (ISO) iron(0) (ISO) ivermectin (ISO) melatonin (ISO) methyl methanesulfonate (ISO) Methylazoxymethanol acetate (EXP) miconazole (EXP) monocrotophos (ISO) N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine (ISO) paracetamol (EXP,ISO) perfluorooctane-1-sulfonic acid (ISO) pirinixic acid (ISO) potassium bromate (ISO) potassium chromate (ISO) rotenone (EXP) SB 431542 (ISO) silver atom (ISO) silver(0) (ISO) sodium arsenite (ISO) sodium dodecyl sulfate (ISO) sodium fluoride (ISO) trichloroethene (EXP) trichostatin A (ISO) trimellitic anhydride (ISO) valproic acid (ISO) zinc atom (ISO) zinc(0) (ISO)
Lig3 (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 10 68,215,371 - 68,238,705 (+) NCBI GRCr8 mRatBN7.2 10 67,717,808 - 67,741,141 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 10 67,717,812 - 67,798,414 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 10 72,337,877 - 72,361,210 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 10 71,843,252 - 71,866,586 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 10 67,305,075 - 67,328,397 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 10 70,134,734 - 70,158,051 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 10 70,134,729 - 70,158,055 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 10 69,765,441 - 69,788,758 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 10 71,000,287 - 71,021,398 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 10 71,013,909 - 71,035,020 (+) NCBI Celera 10 66,662,184 - 66,683,295 (+) NCBI Celera Cytogenetic Map 10 q26 NCBI
LIG3 (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 17 34,980,512 - 35,010,872 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 17 34,980,512 - 35,009,743 (+) Ensembl GRCh38 hg38 GRCh38 GRCh37 17 33,307,531 - 33,336,762 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 17 30,331,651 - 30,356,201 (+) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 17 30,331,696 - 30,355,936 NCBI Celera 17 30,217,714 - 30,242,284 (+) NCBI Celera Cytogenetic Map 17 q12 NCBI HuRef 17 29,493,447 - 29,518,012 (+) NCBI HuRef CHM1_1 17 33,371,911 - 33,396,481 (+) NCBI CHM1_1 T2T-CHM13v2.0 17 35,928,368 - 35,957,659 (+) NCBI T2T-CHM13v2.0
Lig3 (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 11 82,671,977 - 82,695,100 (+) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 11 82,671,934 - 82,695,100 (+) Ensembl GRCm39 Ensembl GRCm38 11 82,781,109 - 82,804,274 (+) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 11 82,781,108 - 82,804,274 (+) Ensembl GRCm38 mm10 GRCm38 MGSCv37 11 82,594,637 - 82,617,776 (+) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 11 82,597,330 - 82,620,469 (+) NCBI MGSCv36 mm8 Celera 11 92,400,612 - 92,423,646 (+) NCBI Celera Cytogenetic Map 11 C NCBI cM Map 11 50.23 NCBI
Lig3 (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955481 9,696,054 - 9,715,637 (+) Ensembl ChiLan1.0 ChiLan1.0 NW_004955481 9,696,050 - 9,716,154 (+) NCBI ChiLan1.0 ChiLan1.0
LIG3 (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 19 29,456,509 - 29,487,762 (-) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 17 31,342,056 - 31,367,159 (-) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 17 21,776,483 - 21,805,706 (-) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 17 22,073,487 - 22,097,754 (-) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 17 22,074,046 - 22,095,220 (-) Ensembl panpan1.1 panPan2
LIG3 (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 9 38,346,275 - 38,366,634 (-) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 9 38,346,199 - 38,366,193 (-) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 9 37,569,261 - 37,590,027 (-) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 9 39,158,185 - 39,178,954 (-) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 9 39,155,826 - 39,178,934 (-) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 9 37,940,790 - 37,961,563 (-) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 9 38,226,708 - 38,247,470 (-) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 9 38,314,196 - 38,334,891 (-) NCBI UU_Cfam_GSD_1.0
Lig3 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
LIG3 (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 12 40,153,397 - 40,183,622 (-) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 12 40,153,105 - 40,205,077 (-) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 12 41,714,491 - 41,773,847 (-) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
LIG3 (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 16 28,487,953 - 28,511,945 (+) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 16 28,490,434 - 28,511,130 (+) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666075 1,476,469 - 1,500,221 (-) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Lig3 (Heterocephalus glaber - naked mole-rat)
.
Predicted Target Of
Count of predictions: 453 Count of miRNA genes: 240 Interacting mature miRNAs: 280 Transcripts: ENSRNOT00000055982 Prediction methods: Microtar, Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
1549846 Scl47 Serum cholesterol level QTL 47 3.6 blood cholesterol amount (VT:0000180) serum total cholesterol level (CMO:0000363) 10 50574707 95574707 Rat 152025229 Scl83 Serum cholesterol level QTL 83 4.33 blood cholesterol amount (VT:0000180) 10 35710580 68663659 Rat 1578779 Tcas10 Tongue tumor susceptibility QTL 10 3.12 tongue integrity trait (VT:0010553) number of squamous cell tumors of the tongue with diameter greater than 3 mm (CMO:0001950) 10 31297439 76297439 Rat 152025227 Bw195 Body weight QTL 195 5.73 body mass (VT:0001259) 10 46989699 68663659 Rat 631565 Hcuc4 Hepatic copper content QTL 4 4.15 liver copper amount (VT:0003065) liver copper weight to liver dry weight ratio (CMO:0001512) 10 66941813 73452992 Rat 1298069 Bp168 Blood pressure QTL 168 5.5 blood pressure trait (VT:0000183) systolic blood pressure (CMO:0000004) 10 26521957 98003205 Rat 8657410 Bp374 Blood pressure QTL 374 heart left ventricle size trait (VT:0002753) heart left ventricle end-diastolic diameter (CMO:0000982) 10 66978955 67750281 Rat 2293669 Bmd33 Bone mineral density QTL 33 4.5 0.0001 femur strength trait (VT:0010010) femoral neck polar moment of inertia (CMO:0001670) 10 49444551 81709989 Rat 152025224 Bw193 Body weight QTL 193 6.47 body mass (VT:0001259) 10 51663405 75085664 Rat 631552 Vetf2 Vascular elastic tissue fragility QTL 2 4.5 0.0002 aorta elastic tissue integrity trait (VT:0010556) artery internal elastic lamina non-tumorous lesion count (CMO:0001913) 10 41142633 86142633 Rat 61449 Ciaa2 CIA Autoantibody QTL 2 7.1 blood autoantibody amount (VT:0003725) calculated serum anti-type 2 collagen antibody titer (CMO:0001279) 10 63221094 107211142 Rat 631557 Bp136 Blood pressure QTL 136 0.003 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 30632053 75632053 Rat 61325 Aia5 Adjuvant induced arthritis QTL 5 0.01 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 23444813 104060283 Rat 1298078 Stresp5 Stress response QTL 5 2.99 0.00025 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 10 42045676 104670812 Rat 2293679 Bmd30 Bone mineral density QTL 30 3.5 0.0001 femur mineral mass (VT:0010011) total volumetric bone mineral density (CMO:0001728) 10 49444551 81709989 Rat 1549831 Bss6 Bone structure and strength QTL 6 4 lumbar vertebra strength trait (VT:0010574) vertebra ultimate force (CMO:0001678) 10 57576521 102576521 Rat 12903252 Cm113 Cardiac mass QTL 113 0.047 heart left ventricle mass (VT:0007031) heart left ventricle weight to body weight ratio (CMO:0000530) 10 66319447 67750281 Rat 70164 Bw21 Body weight QTL 21 4.36 0.00005 body mass (VT:0001259) body weight (CMO:0000012) 10 53797494 98952626 Rat 1579917 Bp282 Blood pressure QTL 282 0.001 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 67400316 68164786 Rat 61463 Bp12 Blood pressure QTL 12 6.3 0.0001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 41333258 86333258 Rat 8694173 Bw149 Body weight QTL 149 4.38 0.001 body mass (VT:0001259) body weight gain (CMO:0000420) 10 44441699 89441699 Rat 2300218 Hpcl2 Hepatic cholesterol level QTL 2 liver cholesterol amount (VT:0010498) liver cholesterol level (CMO:0001597) 10 45029650 95600334 Rat 1554317 Bmd4 Bone mineral density QTL 4 9.4 0.0001 lumbar vertebra mineral mass (VT:0010511) volumetric bone mineral density (CMO:0001553) 10 19816042 99406971 Rat 70171 Cari1 Carrageenan-induced inflammation QTL 1 4.9 0.0005 hypodermis integrity trait (VT:0010550) inflammatory exudate volume (CMO:0001429) 10 53797385 107211142 Rat 12903269 Am15 Aortic mass QTL 15 0.042 aorta mass (VT:0002845) aorta weight to aorta length to body weight ratio (CMO:0002722) 10 66319447 67750281 Rat 724527 Bp148 Blood pressure QTL 148 0.0001 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 28453136 73453136 Rat 12903266 Cm114 Cardiac mass QTL 114 0.02 heart right ventricle mass (VT:0007033) heart right ventricle weight to body weight ratio (CMO:0000914) 10 66319447 67750281 Rat 2300171 Bmd58 Bone mineral density QTL 58 4.9 0.0001 lumbar vertebra mineral mass (VT:0010511) volumetric bone mineral density (CMO:0001553) 10 26944628 71944628 Rat 61354 Pia10 Pristane induced arthritis QTL 10 0.01 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 23444813 104060283 Rat 2301967 Cm73 Cardiac mass QTL 73 4.55 heart left ventricle mass (VT:0007031) heart left ventricle weight to body weight ratio (CMO:0000530) 10 14487011 89062041 Rat 2313103 Bss80 Bone structure and strength QTL 80 2 0.0001 tibia strength trait (VT:1000284) tibia midshaft endosteal cross-sectional area (CMO:0001716) 10 62057807 107057807 Rat 2303118 Mamtr7 Mammary tumor resistance QTL 7 0.003 mammary gland integrity trait (VT:0010552) mammary tumor growth rate (CMO:0000344) 10 9658275 104670812 Rat 70188 BpQTLcluster1 Blood pressure QTL cluster 1 4.864 arterial blood pressure trait (VT:2000000) pulse pressure (CMO:0000292) 1 42323132 87323132 Rat 12880372 Am12 Aortic mass QTL 12 0.003 aorta mass (VT:0002845) aorta weight to aorta length to body weight ratio (CMO:0002722) 10 66319447 68164786 Rat 2313105 Bss79 Bone structure and strength QTL 79 1.8 0.0001 tibia size trait (VT:0100001) tibia midshaft cross-sectional area (CMO:0001717) 10 62057807 107057807 Rat 12880375 Kidm66 Kidney mass QTL 66 0.009 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 10 66319447 68164786 Rat 9589030 Epfw9 Epididymal fat weight QTL 9 19.24 0.001 epididymal fat pad mass (VT:0010421) epididymal fat pad weight to body weight ratio (CMO:0000658) 10 44441699 89441699 Rat 1357344 Bp249 Blood pressure QTL 249 0.0001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 66743655 98003205 Rat 10402859 Bp381 Blood pressure QTL 381 0.002 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 27606468 72606468 Rat 2316949 Gluco60 Glucose level QTL 60 3.7 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 10 14487011 107057807 Rat 2293652 Bmd22 Bone mineral density QTL 22 4.9 0.0001 femur mineral mass (VT:0010011) total volumetric bone mineral density (CMO:0001728) 10 49444551 81709989 Rat 12880370 Cm105 Cardiac mass QTL 105 0.008 heart mass (VT:0007028) heart wet weight to body weight ratio (CMO:0002408) 10 66319447 68164786 Rat 70198 BpQTLcluster9 Blood pressure QTL cluster 9 2.94 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 42323132 87323132 Rat 12880371 Cm106 Cardiac mass QTL 106 0.007 heart left ventricle mass (VT:0007031) heart left ventricle weight to body weight ratio (CMO:0000530) 10 66319447 68164786 Rat 2306970 Anxrr22 Anxiety related response QTL 22 5.95 fear/anxiety-related behavior trait (VT:1000241) number of periods of voluntary immobility (CMO:0001045) 10 61345276 98211570 Rat 1359017 Hrtrt21 Heart rate QTL 21 2.4 heart pumping trait (VT:2000009) heart rate (CMO:0000002) 10 51772940 96772940 Rat 11565453 Kidm58 Kidney mass QTL 58 0.002 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 10 66319447 67750281 Rat 7387312 Bw125 Body weight QTL 125 3 0.0047 retroperitoneal fat pad mass (VT:0010430) retroperitoneal fat pad weight (CMO:0000356) 10 64890616 107211142 Rat 2312672 Insul15 Insulin level QTL 15 0.01 blood insulin amount (VT:0001560) serum insulin level (CMO:0000358) 10 57134272 102134272 Rat 2317029 Aia19 Adjuvant induced arthritis QTL 19 2.98 joint integrity trait (VT:0010548) left rear ankle joint diameter (CMO:0002149) 10 66978955 107211142 Rat 724556 Pur2 Proteinuria QTL 2 5.5 urine protein amount (VT:0005160) urine protein level (CMO:0000591) 10 22427500 90627625 Rat 8662860 Vetf10 Vascular elastic tissue fragility QTL 10 artery integrity trait (VT:0010639) number of ruptures of the internal elastic lamina of the abdominal aorta and iliac arteries (CMO:0002562) 10 6154182 73453136 Rat 61387 Bp1 Blood pressure QTL 1 5.1 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 10 51770177 107211142 Rat 2317039 Aia6 Adjuvant induced arthritis QTL 6 4.31 joint integrity trait (VT:0010548) right rear ankle joint diameter (CMO:0002150) 10 66978955 107211142 Rat 70223 Bp57 Blood pressure QTL 57 5 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 1 80676123 Rat 2317043 Aia7 Adjuvant induced arthritis QTL 7 3.82 joint integrity trait (VT:0010548) left rear ankle joint diameter (CMO:0002149) 10 37565079 82565079 Rat 2317042 Aia20 Adjuvant induced arthritis QTL 20 3.38 joint integrity trait (VT:0010548) right rear ankle joint diameter (CMO:0002150) 10 37565079 82565079 Rat 2298481 Eau9 Experimental allergic uveoretinitis QTL 9 0.0169 uvea integrity trait (VT:0010551) experimental autoimmune uveitis score (CMO:0001504) 10 65927233 82565079 Rat 70363 Bp71 Blood pressure QTL 71 0.04 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 61345276 81714865 Rat 61402 Niddm3 Non-insulin dependent diabetes mellitus QTL 3 4.58 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 10 61345413 82564856 Rat 1331791 Cm31 Cardiac mass QTL 31 3.84606 heart mass (VT:0007028) heart wet weight (CMO:0000069) 10 29299504 107211142 Rat 70364 Bp72 Blood pressure QTL 72 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 51121100 96121100 Rat 2293698 Bss43 Bone structure and strength QTL 43 5.33 0.0001 lumbar vertebra size trait (VT:0010518) lumbar vertebra cross-sectional area (CMO:0001689) 10 59209888 104209888 Rat 631530 Tls3 T-lymphoma susceptibility QTL 3 0 0.0001 thymus integrity trait (VT:0010555) percentage of study population developing T-cell lymphomas during a period of time (CMO:0001911) 10 51774612 95600334 Rat 2289985 Bp305 Blood pressure QTL 305 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 67502108 73579767 Rat 1354608 Cm33 Cardiac mass QTL 33 2.8 heart left ventricle mass (VT:0007031) heart left ventricle wet weight (CMO:0000071) 10 54809292 99809292 Rat 1558643 Cm44 Cardiac mass QTL 44 4.8 0.0000368 heart mass (VT:0007028) heart wet weight (CMO:0000069) 10 61345276 99703528 Rat 631535 Cm51 Cardiac mass QTL 51 3 heart mass (VT:0007028) calculated heart weight (CMO:0000073) 10 51786282 91669536 Rat 1576319 Cia29 Collagen induced arthritis QTL 29 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 33973921 78973921 Rat 8552805 Bw145 Body weight QTL 145 2.2 body mass (VT:0001259) change in body weight to body weight ratio (CMO:0002216) 10 41944526 78307017 Rat 631267 Cia20 Collagen induced arthritis QTL 20 3.2 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 23444813 104060283 Rat 2293705 Bmd25 Bone mineral density QTL 25 7.1 0.0001 femur mineral mass (VT:0010011) compact volumetric bone mineral density (CMO:0001730) 10 49444551 81709989 Rat 1331839 Eae18b Experimental allergic encephalomyelitis QTL 18b 5.8 0.03 nervous system integrity trait (VT:0010566) experimental autoimmune encephalomyelitis severity score (CMO:0001419) 10 61248303 67785171 Rat 1576308 Schws1 Schwannoma susceptibility QTL 1 0.0041 nervous system integrity trait (VT:0010566) percentage of study population developing trigeminal nerve neurilemmomas during a period of time (CMO:0002017) 10 40035094 102359817 Rat 631269 Cia22 Collagen induced arthritis QTL 22 8.9 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 40035094 104060283 Rat 631268 Cia21 Collagen induced arthritis QTL 21 3.1 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 14487011 104060283 Rat 7207811 Bmd90 Bone mineral density QTL 90 5.2 femur size trait (VT:1000369) femoral neck cross-sectional area (CMO:0001697) 10 49444551 81709989 Rat 1576311 Pia26 Pristane induced arthritis QTL 26 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 31224026 75632053 Rat 631270 Cia23 Collagen induced arthritis QTL 23 3.9 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 40035094 104060283 Rat 7411614 Foco18 Food consumption QTL 18 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 10 44441699 89441699 Rat 6893336 Cm75 Cardiac mass QTL 75 0.1 0.87 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 10 61345276 99703528 Rat 631547 Bp87 Blood pressure QTL 87 4.5 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 47369470 92369470 Rat 61427 Cia16 Collagen induced arthritis QTL 16 3.2 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 6357896 96121100 Rat 2312662 Slep8 Serum leptin concentration QTL 8 0.05 blood leptin amount (VT:0005667) serum leptin level (CMO:0000780) 10 57134272 102134272 Rat 6893342 Cm78 Cardiac mass QTL 78 0.1 0.88 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 10 42876766 79813922 Rat 2292441 Bp308 Blood pressure QTL 308 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 27606468 72606468 Rat 2301405 Cm69 Cardiac mass QTL 69 0.031 heart mass (VT:0007028) heart wet weight to body weight ratio (CMO:0002408) 10 66319447 67750281 Rat 631542 Bp82 Blood pressure QTL 82 6.8 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 26521957 98952741 Rat 2312668 Scl65 Serum cholesterol level QTL 65 0.001 blood cholesterol amount (VT:0000180) serum total cholesterol level (CMO:0000363) 10 57134272 102134272 Rat
D10Chm170
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 10 67,720,219 - 67,720,443 (+) MAPPER mRatBN7.2 Rnor_6.0 10 70,137,131 - 70,137,354 NCBI Rnor6.0 Rnor_5.0 10 69,767,838 - 69,768,061 UniSTS Rnor5.0 RGSC_v3.4 10 71,002,650 - 71,002,873 UniSTS RGSC3.4 Celera 10 66,664,547 - 66,664,770 UniSTS Cytogenetic Map 10 q26 UniSTS
BE109015
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 10 67,728,917 - 67,729,074 (+) MAPPER mRatBN7.2 Rnor_6.0 10 70,145,829 - 70,145,985 NCBI Rnor6.0 Rnor_5.0 10 69,776,536 - 69,776,692 UniSTS Rnor5.0 RGSC_v3.4 10 71,011,348 - 71,011,504 UniSTS RGSC3.4 Celera 10 66,673,245 - 66,673,401 UniSTS Cytogenetic Map 10 q26 UniSTS
RH134877
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 10 67,716,622 - 67,716,808 (+) MAPPER mRatBN7.2 Rnor_6.0 10 70,133,534 - 70,133,719 NCBI Rnor6.0 Rnor_5.0 10 69,764,241 - 69,764,426 UniSTS Rnor5.0 RGSC_v3.4 10 70,999,053 - 70,999,238 UniSTS RGSC3.4 Celera 10 66,660,950 - 66,661,135 UniSTS Cytogenetic Map 10 q26 UniSTS
RH141104
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 10 67,739,005 - 67,739,212 (+) MAPPER mRatBN7.2 Rnor_6.0 10 70,155,916 - 70,156,122 NCBI Rnor6.0 Rnor_5.0 10 69,786,623 - 69,786,829 UniSTS Rnor5.0 RGSC_v3.4 10 71,021,435 - 71,021,641 UniSTS RGSC3.4 Celera 10 66,683,332 - 66,683,538 UniSTS Cytogenetic Map 10 q26 UniSTS
MARC_3929-3930:996679185:1
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 10 67,733,525 - 67,734,591 (+) MAPPER mRatBN7.2 Rnor_6.0 10 70,150,436 - 70,151,501 NCBI Rnor6.0 Rnor_5.0 10 69,781,143 - 69,782,208 UniSTS Rnor5.0 RGSC_v3.4 10 71,015,955 - 71,017,020 UniSTS RGSC3.4 Celera 10 66,677,852 - 66,678,917 UniSTS Cytogenetic Map 10 q26 UniSTS
Lig3
Rat Assembly Chr Position (strand) Source JBrowse GRCr8 10 68,224,677 - 68,225,542 (+) Marker Load Pipeline mRatBN7.2 10 67,727,114 - 67,727,979 (+) MAPPER mRatBN7.2 Rnor_6.0 10 70,144,026 - 70,144,890 NCBI Rnor6.0 Rnor_5.0 10 69,774,733 - 69,775,597 UniSTS Rnor5.0 RGSC_v3.4 10 71,009,545 - 71,010,409 UniSTS RGSC3.4 Celera 10 66,671,442 - 66,672,306 UniSTS Cytogenetic Map 10 q26 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
91
90
59
25
59
6
218
97
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000055982 ⟹ ENSRNOP00000052836
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 10 67,717,857 - 67,738,968 (+) Ensembl Rnor_6.0 Ensembl 10 70,134,768 - 70,155,881 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000076703 ⟹ ENSRNOP00000068142
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source Rnor_6.0 Ensembl 10 70,153,427 - 70,154,512 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000076739 ⟹ ENSRNOP00000068489
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 10 67,717,812 - 67,741,142 (+) Ensembl Rnor_6.0 Ensembl 10 70,134,729 - 70,158,055 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000084076 ⟹ ENSRNOP00000069379
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 10 67,717,812 - 67,798,414 (+) Ensembl Rnor_6.0 Ensembl 10 70,136,855 - 70,156,772 (+) Ensembl
RefSeq Acc Id:
NM_001394035 ⟹ NP_001380964
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 10 68,215,371 - 68,238,703 (+) NCBI mRatBN7.2 10 67,717,808 - 67,741,141 (+) NCBI
RefSeq Acc Id:
NM_001394036 ⟹ NP_001380965
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 10 68,215,371 - 68,238,703 (+) NCBI mRatBN7.2 10 67,717,808 - 67,741,141 (+) NCBI
RefSeq Acc Id:
NR_172067
RefSeq Status:
VALIDATED
Type:
NON-CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 10 68,215,371 - 68,238,703 (+) NCBI mRatBN7.2 10 67,717,808 - 67,741,141 (+) NCBI
RefSeq Acc Id:
XM_008768020 ⟹ XP_008766242
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 10 68,215,595 - 68,238,705 (+) NCBI mRatBN7.2 10 67,719,943 - 67,741,141 (+) NCBI Rnor_6.0 10 70,134,922 - 70,158,051 (+) NCBI
Sequence:
TGGCTCCTCCCCCGCCCGCCGCTCAGCCTGGGGGCACACCCTCCGTGACGTGGCGGCCCCCCGGGAGCCCACGGGAGGCCCGCGGCCCCCGGGACCCCAGGCGGGCACCCGGAAGGGCAGGATGCTGC TGGCGGCAGAGTGGGCATCCTCAGGGGTCGAGGCCGGGCCGCTGCTGGTCCTCCCCGCCGCCTTGTGGCGCGGCGGGCTCAACCCGTGGGCAGAGCGGCGTGCTGCTTGCTCTTCGGGGGGGGGGGGG GGCTCCAGAGCCTCTCCGCGCTGGTCTCCCCCTGTAGTTAGTTGTCGTATCCCGGGCTGGACGACACGGCACCCCACCCACCCTAATCTGCGGAAAGTTGAACTCCTATCCGCCCGGAGCACCTCCCC AGCCCTGCCGGCCTTCACTCGCCTCTGTGATTCTTAACCGTTAGGGCTTATGTGACCCACTGAGTCTGCCAGTTACGGACTTCTCCTCCCCCAAATCGAATATTTTCAAAGTTTGGTATATATCCTCC GGGAGTTCCGAACTCCACCTCTGGCCTGCCCTCGTATGCGTTGTACTTTTCCTAACCAATTCATGAAGTAGTTCTAATCTTTGGGGGGTGGGGGAGGAGTTGTTATCCTTTTGAGACGATCTTGGCTA TGTATCCCTAGATAGACAGAAATTTACTAAGTAAACCAGACTGTCCAACTTCGAACGCACAGCAATGCCTTCTGAGGGATGAGATTACAGGAGAGAGCCACCATAACTAGCTTAGTCCTGTTTTTTAA ACTAAAACTGGGGCCGGGTATAGTAGCACATGCCTTTAATCCGTGCACTCAGAACAGTAGTTTGCTCTGCATCGTGACTCCCAGGACAGCCAGGGCTACATAGAAAGATCCTGTCTCAAAAGGCGAAA AATAAACAGACAATAAACTGGTCATGCTTGGTGGCTCACACCTACCATCCCAGCACTGGAGGTGGGAGGATCAGCTAGCTAGGGTCAACCTTGTTGGAGGAAACCGAGTCACCTGGTATCTGCCCCAC TTTCCTGCCCCCTTTTAGCTGGATAGACTTGGCTTCCCAACCCCTTCTTAAATAGTATACCTGCTGTGTTCTGCACCATGTCGCACAGCAGTGATGGAAGCCAGCTTGCTGTTCTGACACAATATTCA TTTTACTTCTCAGCAGAGTGGGGACTAAAAATAGTTTCCAGTAAATTGGAAATTAAAACTGTAAAGCCACTTAAATAATTATAAATATAAGAGTAAGAATAATAATTTTCCACTTGAATTGATTCATC ACTTGGTTAGATCTTACAGTCCGGTTATTTCAACCTCCCTGATTCAGGTAGCCGAATTAAGCAAGGGGATTGCTTATTCTGTTTCTAAGGACTTTCCTCTTAGCACAACTGACTACTCCTTGAATTAG GTCCTACTGTGAGCTGCAGTTGACAGATGAAATAGGAACAGAGAGGTAAAGTAACTGAACCAAGGTCACACAGCTGATAAATGGCTAAGGTTTTGAACTCAGGCAGTCAATCTGATTATAGACTCTGA TTAGTTGCCTCGAAAAGGGGGCCTTCTTCTGAAATCCCAAAACTGTTACAGTGGCTGATTTGTTTTCTGAAAGTGGCTCATGTGTTATGTTTCACAGGAAAATTTCATAAACATAATGTAATTTTTCT TGGTTTTTAAGACAGCTTCAGGATCCTGGTAATATTTAAAGGTCACCATCGATTATGAGTGCCTTTACAGTCTCTACAATGTTGACGAGGCATGCCCCTTTGGAAACTGGTTTTTCCTGTATTGGAAC TCTGGGTGGTAAATATTTAATGCATTGGGAAGTGCTTGGTTAATCAAGTGCTCTGTCTGAGATTCTAGCTGTTAAGAAGTTGGAAGCCTGGATCCCTCATGTCTGTCTGTCTGTCTGTCTGTTTCCAC CCTTTTATGCAGCTATATGACTTTGGCCTTTAAGACCCTCTTCCCGAGAAACCTCTGTGCCCTTGGCAGAAAAGAACTGTGCCTGTTTTCAGAACAGCATCACTGGCCTGCCATAAGACAGTTCAGCC AGTGGTCGGAAACAAATCTCCTTTGTGGGTGCTGCCTCCTCCAGAGAAGAAAGCCTGTCCTATCTTTCCAGAGAGGTCATCTAAGACCACGTGCCACCCACCTTATTTCGTGGTCAGGGTCGCATGTG GGACTCTGTACTGGCCCCTGTGAGATGGCCGAACAGCGGTTCTGTGTGGACTATGCCAAGCGGGGCACAGCTGGCTGCAAGAAATGCAAGGAGAAGATTGTAAAGGGCGTATGCCGCATTGGCAAAGT GGTACCCAATCCCTTCTCAGAGTCTGGGGGTGATATGAAAGAGTGGTACCACATTAAGTGCATGTTTGAGAAACTGGAGCGGGCGCGGGCCACCACAAAAAAAATTGAAGACCTCACAGAGCTGGAAG GCTGGGAAGAGCTGGAAGATAATGAAAAGGAACAGATAAGCCAGCACATTGCAGACCTGTCTTCCAAGACAGCTGCCACACCGAAGAAGAAAGCTACTGTCCAGGCTAAGCTGACAACCACTGGCCAA GTGACATCACCAGTGAAAGGCGCTTCGTTTATTACCAGTACCAATCCCCGGAAATTTTCTGGCTTTTCAGCCAAACCGAACAACTCTGAGCAAGACCCCTCAAGCCCTGCTCCTAAGACCAGTCTGTC CGCAAGTAAATGTGACCCTAAGCACAAAGATTGTCTACTACGAGAATTCCGGAAGCTGTGTGCCATGGTAGCTGAAAATCCTAGCTATAACACCAAGACCCAGATCATCCACGACTTCTTGCAGAAAG GCTCCACAGGAGATGGCTTCCGAGGCGATGTGTACCTGACAGTGAAGCTGCTGCTGCCTGGTGTCATCAAGAGTGTGTACAACTTGAATGATAAGCAGATAGTGAAACTGTTCAGCCGAATTTTTAAC TGCAACCCAGATGATATGGCCCGGGACCTAGAACAGGGTGACGTGTCCGAGACGATCAGAGTCTTCTTTGAGCAGAGCAAGTCTTTTCCCCCAGCTGCCAAAAGCCTCCTCACCATCCAGGAGGTGGA TGCATTTCTTCTGCACCTCTCCAAGCTCACCAAAGAGGATGAGCAGCAGCAGGCCCTGCAGGACATTGCTTCCAGGTGTACAGCCAATGACCTTAAGTGCATTATCCGGCTGATCAAACACGATCTGA AGATGAACTCGGGTGCAAAACACGTGTTAGATGCCCTTGACCCCAATGCTTATGAAGCCTTCAAAGCATCACGCAACCTGCAGGATGTGGTGGAGCGGGTCCTTCACAATGAGCAGGAGGTGGAGAAG GACCCAGGCCGGCGTCGGGCTCTGAGTGTCCAGGCCTCATTGATGACACCTGTGCAACCCATGCTGGCTGAGGCCTGCAAGTCCATTGAGTATGCAATGAAGAAGTGTCCCAATGGCATGTTCTCTGA GATCAAGTACGATGGTGAGCGAGTCCAGGTGCATAAGAAGGGAGACCATTTCAGCTACTTCAGCCGCAGTCTCAAGCCTGTCTTGCCTCACAAGGTGGCCCACTTTAAGGACTATATTCCCAAAGCGT TTCCTGGGGGTCAAAGCATGATCTTGGACTCTGAAGTGCTCCTGATTGATAACAACACAGGCAAACCACTGCCCTTTGGGACCCTGGGAGTACACAAGAAAGCTGCTTTCCAGGATGCTAATGTCTGC CTGTTTGTTTTTGATTGTATCTACTTTAATGATGTCAGCTTGATGGACAGGCCTCTCTGTGAGCGACGGAAGTTTCTTCATGATAACATGGTTGAAATCCGTAACCGGATCATGTTCTCAGAAATGAA GCAAGTCACAAAAGCTTCAGACCTGGCTGACATGATAAACCGGGTGATCCGAGAGGGCCTGGAAGGTTTGGTGCTAAAGGATGTGAAGGGTACATATGAGCCTGGAAAACGACACTGGCTGAAAGTTA AGAAAGACTATTTGAACGAGGGGGCCATGGCTGATACAGCTGATCTGGTGGTTCTTGGGGCCTTCTATGGGCAAGGGAGCAAAGGTGGAATGATGTCCATCTTCCTCATGGGCTGCTATGACCCCGAC AGCCAGAAGTGGTGCACTGTTACAAAATGTGCTGGAGGCCATGACGATGCCACACTTGCCCGCCTGCAGAAAGAGCTAGATATGGTGAAGATTAGCAAGGATCCTAGCAAGATACCCAGCTGGCTGAA GATCAACAAGATCTACTATCCTGACTTTATCGTCCCAGACCCAAAGAAAGCTGCTGTGTGGGAGATCACAGGAGCAGAATTCTCTCGATCTGAGGCGCATACTGCTGATGGGATCTCCATCCGATTTC CTCGATGCACCCGAATCCGGGATGACAAGGACTGGAAATCTGCCACTAACCTCCCCCAACTCAAGGAACTGTACCAGCTGTCCAAAGACAAGGCAGACTTCGCTGTGGTGGCTGGAGATGAGGGGAGC TCCACTACTGGAGGCAGCAATGGTGAGAATGAGGGCACTGCTGGGTCTACTGTGCCCCGCAAGGGCCCCAAGGGACCCCCCAGTAAGTCCTCTGCCAGTGCCAAGAAGACTGAACAGAAGCTGAATGA TCCCAGTAGCAGAGGTGGAGAGAAGCTGGCTGTGAAGTCTTCTCCTGTCAAAGTGGGGATGAAGAGGAAAGCTGCTGATGAGACCCCAGGCCTGACAAAGGCGCTGTTGGATGTCTTCACTGGGGTGA GGCTCTACTTGCCACCTTCTACACCAGACTTCAGACGGCTCAAACGTTACTTTGTGGCATTCAACGGGGACCTGGTACAGGAATTTGACATGGCCTCAGCCACACATGTGCTGGGTAACAGGGACAAG AACACTGATGCCCAGTTGGTCTCTTCAGAGTGGATTTGGGCATGCATCCGGAAACGGAGGCTGGTAGCTCCCTGCTAGGACTTTGCTTTTCCTGCTAACTCTACCGATACACGAGGCTCAGCCTGACG GGTAGAGGCCTGTTCGCCAAGCAGCGCACCTTCTCACATCCTCCGCCTCTTTATGGTCTCTTCTGGATCGGGAGTTAGCTGCTGTGGACACAAGCAGTTTAATTGGATCTTCCCAGGTGCTAGTTTTG TCTGAGGTGCTGATGACCAACTTAAACCCTCAATCACACTAGGCACAGCACTCTGCCACTGAACTACAGCTTTATAAATAAGAAATGGGGATCAGAAGTTCAAGGCTAGCCTGGGGTAAGAATTTGAA CAAGAATAAGCATACTTTCCCCCACTGGTCCCATCTAGTGTTCCTCAGTGACGAAGGAGTGCTGAGCGGAATCTACTTCCTGTGCTCCTCGCTTCCACGTGCATCTTAAAGGTGTATTTAAACTGTTC TCAAACACTTCTTATACCTGGCAAAACCTTTATTATGTCTGGTCCAAACCCCCATGTGAAAGAACAAAGTGGTCTCCAAATTTCCAGGTCATTGCCTGGAGGGAGAGCTGACATCTACAGAAAAGTGT CCTCCTTGGAGACAGAGGCTCCTTGAAGGTGAATTTGCCTCATCAAAATCTGACTGCTCTCAGCAGCACAGGTCCATAGCTGGGAAAATCTACATACCCTGCCTACCAAGGTTGGCTTCTATGCCATG TGTGGCAGATGTCCTTGAAGGGGAAAGAAAATGATTTCTGTGTATAACTGCACACAAGGGGTATTTTGCCACAGTGGAAGTGTCCTAAACTAGCCTTATCTGATTGTCAAGCCTTGAAATGGGATTAG TGTGACTGGCGAAAGCCATAAACATTTCAAGACATCTTCAAATGGTCTCAAGTTACCGGTGACATCACATCATCTGAGTATCAGTTCCTCAAGAGGAATGGGCAGTCACTGTTGCCAAATCACTGGGC AGCGGCCAGTAACCTCAGACACCTTGTTGAAGGCATGCAACACGGAGCCTGGTAAAGATATTATCCAGGAGGAGGCCTAGCTTACACCTCACTTGTTAAAAGTTCACATTTGGGTCTAAGCATGGAAC TGTAGTAGACCGCCTTCTTTGTCTATGTTGTGCCACCTCTTGAAGAGCAGCTCTGTTCTTATTAACTCAGCAGGCTTTTCTATCCACCTGTGAGCTAGGTTAATATGATGGGACCTCTTAAACACTTA TGTGAGCCTCTAAGATACAGACCTACCACCCCACGTAACTCCTAAAGTAACATCCCACTAGGAGGCTGCTTACTAGTCTGGCTGTCTTTCTCCTATTTTATAGATGCTCTGACTAGGGTAGAGTAAGC GACATTCAGTCTGGTAAGTTAAACTTTTTTTATTCTAGCCTCAAGGCGGAAGCTGCTTTGTGCTTTGAACACTTGGCTTCCTTGCCCAAGCAGCTTGGTAGAGCATCAAAGATGACTTCCCCATCACA CAGGGCTGGAAGTTTGTCCCTTTGTCCCTTTAATGCCTTACTATATAGTCACTTCAGCTTGCTGTCTGTACATTTCCCTTTGCAGAGGTTAGGCTGTATGTAGACCTTTGTATCTTTCCTGTCTTTCC ACACAAGCCTAAGCATGACCTGAAACCCCCATCCCCCAAGGCTGGAAACATGCTCTCTGTGGCTTTTGTTTACACAATGCCAGTTGATGGCAGGCAGTGCTCATTATGGGATGCTCAACAGATCCGGC CATCAATAAGAGACAGGGTAGAATCCTTTCATCCAGCTCTCCCATAGGTGATACACTCCACTCCACTCCCCTTAGGCACCTGGTCAGGTAGGTGGGTACAGGCCTGTGTCTACTCTGCAGTCTGCTCT TTAGGCTGGGCCAACCTTGGAGCCACACTTGTCTGTATCCAAACGCTACTGTCAGTGTTTTGGGGTAACTTGAAAACTTAACTGCCTACCTAGCTGTCTTGAGATTCCTTTCACTTAGCTCTTGAAGG CCCCTCTACAGTGGGACTGTAATAACTTCACACGGTGCTTGCCGTTTGCTCTTGAATCACCCTTACACTTAGCTCCACGAGTAACTGTTCCACAATCCCATGTACTCTTGTGGATCTTGGCCAGGTCA CAACACAGAGCATGTGGCCTGATGTCTGCCCACGTTTACAAGTGTTTTGGGAACCTCTGGTATCATCCCCCCACACCAGATGGAACAGGCATCTGTATTTAAACTTTATTACAAAATTATAAAGCAGA GCTCTGTAACAAAAAATACACATTTGGGTATGCTTACCACCCAGGTGAGAGAATCAATGTAAGCCACTTGGAGCTATACATTTATATCCAAGAGATCTCAAATGTGTACAACATAGACTATTAATTCC TTTACAGCTTGTTAGTTTAGAACCGGCTATTCCAACCAGTCAGCATCTTTGAAAACTAAGTCTCAACTAAAATCTTGGCGCAATCGGCAAAGTCCACAGAATAATTGGAAGGATTAGGTGTTTCCACA TTAATTAAGACCAAGGATCCGTGAAGAACAGAAAAAGGGGCTCAGGTATTTAAAAAAAAAAATCAGTTTTTCTACCTGAGATATTAACTGGAATGAGTTCCAACTTCCATTTGGTTTAACAATAAAAA GGTTATTTGA
hide sequence
RefSeq Acc Id:
XM_008768021 ⟹ XP_008766243
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 10 68,215,602 - 68,238,705 (+) NCBI mRatBN7.2 10 67,719,943 - 67,741,141 (+) NCBI Rnor_6.0 10 70,134,925 - 70,158,051 (+) NCBI
Sequence:
CTCCTCCCCCGCCCGCCGCTCAGCCTGGGGGCACACCCTCCGTGACGTGGCGGCCCCCCGGGAG CCCACGGGAGGCCCGCGGCCCCCGGGACCCCAGGCGGGCACCCGGAAGGGCAGGATGCTGCTGGCGGCAGAGTGGGCATCCTCAGGGGTCGAGGCCGGGCCGCTGCTGGTCCTCCCCGCCGCCTTGTG GCGCGGCGGGCTCAACCCGTGGGCAGAGCGGCGTGCTGCTTGCTCTTCGGGGGGGGGGGGGGGCTCCAGAGCCTCTCCGCGCTGGTCTCCCCCTGTAGTTAGTTGTCGTATCCCGGGCTGGACGACAC GGCACCCCACCCACCCTAATCTGCGGAAAGTTGAACTCCTATCCGCCCGGAGCACCTCCCCAGCCCTGCCGGCCTTCACTCGCCTCTGTGATTCTTAACCGTTAGGGCTTATGTGACCCACTGAGTCT GCCAGTTACGGACTTCTCCTCCCCCAAATCGAATATTTTCAAAGTTTGGTATATATCCTCCGGGAGTTCCGAACTCCACCTCTGGCCTGCCCTCGTATGCGTTGTACTTTTCCTAACCAATTCATGAA GTAGTTCTAATCTTTGGGGGGTGGGGGAGGAGTTGTTATCCTTTTGAGACGATCTTGGCTATGTATCCCTAGATAGACAGAAATTTACTAAGTAAACCAGACTGTCCAACTTCGAACGCACAGCAATG CCTTCTGAGGGATGAGATTACAGGAGAGAGCCACCATAACTAGCTTAGTCCTGTTTTTTAAACTAAAACTGGGGCCGGGTATAGTAGCACATGCCTTTAATCCGTGCACTCAGAACAGTAGTTTGCTC TGCATCGTGACTCCCAGGACAGCCAGGGCTACATAGAAAGATCCTGTCTCAAAAGGCGAAAAATAAACAGACAATAAACTGGTCATGCTTGGTGGCTCACACCTACCATCCCAGCACTGGAGGTGGGA GGATCAGCTAGCTAGGGTCAACCTTGTTGGAGGAAACCGAGTCACCTGGTATCTGCCCCACTTTCCTGCCCCCTTTTAGCTGGATAGACTTGGCTTCCCAACCCCTTCTTAAATAGTATACCTGCTGT GTTCTGCACCATGTCGCACAGCAGTGATGGAAGCCAGCTTGCTGTTCTGACACAATATTCATTTTACTTCTCAGCAGAGTGGGGACTAAAAATAGTTTCCAGTAAATTGGAAATTAAAACTGTAAAGC CACTTAAATAATTATAAATATAAGAGTAAGAATAATAATTTTCCACTTGAATTGATTCATCACTTGGTTAGATCTTACAGTCCGGTTATTTCAACCTCCCTGATTCAGGTAGCCGAATTAAGCAAGGG GATTGCTTATTCTGTTTCTAAGGACTTTCCTCTTAGCACAACTGACTACTCCTTGAATTAGGTCCTACTGTGAGCTGCAGTTGACAGATGAAATAGGAACAGAGAGGTAAAGTAACTGAACCAAGGTC ACACAGCTGATAAATGGCTAAGGTTTTGAACTCAGGCAGTCAATCTGATTATAGACTCTGATTAGTTGCCTCGAAAAGGGGGCCTTCTTCTGAAATCCCAAAACTGTTACAGTGGCTGATTTGTTTTC TGAAAGTGGCTCATGTGTTATGTTTCACAGGAAAATTTCATAAACATAATGTAATTTTTCTTGGTTTTTAAGACAGCTTCAGGATCCTGGTAATATTTAAAGGTCACCATCGATTATGAGTGCCTTTA CAGTCTCTACAATGTTGACGAGGCATGCCCCTTTGGAAACTGGTTTTTCCTGTATTGGAACTCTGGGTGGTAAATATTTAATGCATTGGGAAGTGCTTGGTTAATCAAGTGCTCTGTCTGAGATTCTA GCTGTTAAGAAGTTGGAAGCCTGGATCCCTCATGTCTGTCTGTCTGTCTGTCTGTTTCCACCCTTTTATGCAGCTATATGACTTTGGCCTTTAAGACCCTCTTCCCGAGAAACCTCTGTGCCCTTGGC AGAAAAGAACTGTGCCTGTTTTCAGAACAGCATCACTGGCCTGCCATAAGACAGTTCAGCCAGTGGTCGGAAACAAATCTCCTTTGTGGGTGCTGCCTCCTCCAGAGAAGAAAGCCTGTCCTATCTTT CCAGAGAGGTCATCTAAGACCACGTGCCACCCACCTTATTTCGTGGTCAGGGTCGCATGTGGGACTCTGTACTGGCCCCTGTGAGATGGCCGAACAGCGGTTCTGTGTGGACTATGCCAAGCGGGGCA CAGCTGGCTGCAAGAAATGCAAGGAGAAGATTGTAAAGGGCGTATGCCGCATTGGCAAAGTGGTACCCAATCCCTTCTCAGAGTCTGGGGGTGATATGAAAGAGTGGTACCACATTAAGTGCATGTTT GAGAAACTGGAGCGGGCGCGGGCCACCACAAAAAAAATTGAAGACCTCACAGAGCTGGAAGGCTGGGAAGAGCTGGAAGATAATGAAAAGGAACAGATAAGCCAGCACATTGCAGACCTGTCTTCCAA GACAGCTGCCACACCGAAGAAGAAAGCTACTGTCCAGGCTAAGCTGACAACCACTGGCCAAGTGACATCACCAGTGAAAGGCGCTTCGTTTATTACCAGTACCAATCCCCGGAAATTTTCTGGCTTTT CAGCAGCCAAACCGAACAACTCTGAGCAAGACCCCTCAAGCCCTGCTCCTAAGACCAGTCTGTCCGCAAGTAAATGTGACCCTAAGCACAAAGATTGTCTACTACGAGAATTCCGGAAGCTGTGTGCC ATGGTAGCTGAAAATCCTAGCTATAACACCAAGACCCAGATCATCCACGACTTCTTGCAGAAAGGCTCCACAGGAGATGGCTTCCGAGGCGATGTGTACCTGACAGTGAAGCTGCTGCTGCCTGGTGT CATCAAGAGTGTGTACAACTTGAATGATAAGCAGATAGTGAAACTGTTCAGCCGAATTTTTAACTGCAACCCAGATGATATGGCCCGGGACCTAGAACAGGGTGACGTGTCCGAGACGATCAGAGTCT TCTTTGAGCAGAGCAAGTCTTTTCCCCCAGCTGCCAAAAGCCTCCTCACCATCCAGGAGGTGGATGCATTTCTTCTGCACCTCTCCAAGCTCACCAAAGAGGATGAGCAGCAGCAGGCCCTGCAGGAC ATTGCTTCCAGGTGTACAGCCAATGACCTTAAGTGCATTATCCGGCTGATCAAACACGATCTGAAGATGAACTCGGGTGCAAAACACGTGTTAGATGCCCTTGACCCCAATGCTTATGAAGCCTTCAA AGCATCACGCAACCTGCAGGATGTGGTGGAGCGGGTCCTTCACAATGAGCAGGAGGTGGAGAAGGACCCAGGCCGGCGTCGGGCTCTGAGTGTCCAGGCCTCATTGATGACACCTGTGCAACCCATGC TGGCTGAGGCCTGCAAGTCCATTGAGTATGCAATGAAGAAGTGTCCCAATGGCATGTTCTCTGAGATCAAGTACGATGGTGAGCGAGTCCAGGTGCATAAGAAGGGAGACCATTTCAGCTACTTCAGC CGCAGTCTCAAGCCTGTCTTGCCTCACAAGGTGGCCCACTTTAAGGACTATATTCCCAAAGCGTTTCCTGGGGGTCAAAGCATGATCTTGGACTCTGAAGTGCTCCTGATTGATAACAACACAGGCAA ACCACTGCCCTTTGGGACCCTGGGAGTACACAAGAAAGCTGCTTTCCAGGATGCTAATGTCTGCCTGTTTGTTTTTGATTGTATCTACTTTAATGATGTCAGCTTGATGGACAGGCCTCTCTGTGAGC GACGGAAGTTTCTTCATGATAACATGGTTGAAATCCGTAACCGGATCATGTTCTCAGAAATGAAGCAAGTCACAAAAGCTTCAGACCTGGCTGACATGATAAACCGGGTGATCCGAGAGGGCCTGGAA GGTTTGGTGCTAAAGGATGTGAAGGGTACATATGAGCCTGGAAAACGACACTGGCTGAAAGTTAAGAAAGACTATTTGAACGAGGGGGCCATGGCTGATACAGCTGATCTGGTGGTTCTTGGGGCCTT CTATGGGCAAGGGAGCAAAGGTGGAATGATGTCCATCTTCCTCATGGGCTGCTATGACCCCGACAGCCAGAAGTGGTGCACTGTTACAAAATGTGCTGGAGGCCATGACGATGCCACACTTGCCCGCC TGCAGAAAGAGCTAGATATGGTGAAGATTAGCAAGGATCCTAGCAAGATACCCAGCTGGCTGAAGATCAACAAGATCTACTATCCTGACTTTATCGTCCCAGACCCAAAGAAAGCTGCTGTGTGGGAG ATCACAGGAGCAGAATTCTCTCGATCTGAGGCGCATACTGCTGATGGGATCTCCATCCGATTTCCTCGATGCACCCGAATCCGGGATGACAAGGACTGGAAATCTGCCACTAACCTCCCCCAACTCAA GGAACTGTACCAGCTGTCCAAAGACAAGGCAGACTTCGCTGTGGTGGCTGGAGATGAGGGGAGCTCCACTACTGGAGGCAGCAATGGAGAGAAGCTGGCTGTGAAGTCTTCTCCTGTCAAAGTGGGGA TGAAGAGGAAAGCTGCTGATGAGACCCCAGGCCTGACAAAGGCGCTGTTGGATGTCTTCACTGGGGTGAGGCTCTACTTGCCACCTTCTACACCAGACTTCAGACGGCTCAAACGTTACTTTGTGGCA TTCAACGGGGACCTGGTACAGGAATTTGACATGGCCTCAGCCACACATGTGCTGGGTAACAGGGACAAGAACACTGATGCCCAGTTGGTCTCTTCAGAGTGGATTTGGGCATGCATCCGGAAACGGAG GCTGGTAGCTCCCTGCTAGGACTTTGCTTTTCCTGCTAACTCTACCGATACACGAGGCTCAGCCTGACGGGTAGAGGCCTGTTCGCCAAGCAGCGCACCTTCTCACATCCTCCGCCTCTTTATGGTCT CTTCTGGATCGGGAGTTAGCTGCTGTGGACACAAGCAGTTTAATTGGATCTTCCCAGGTGCTAGTTTTGTCTGAGGTGCTGATGACCAACTTAAACCCTCAATCACACTAGGCACAGCACTCTGCCAC TGAACTACAGCTTTATAAATAAGAAATGGGGATCAGAAGTTCAAGGCTAGCCTGGGGTAAGAATTTGAACAAGAATAAGCATACTTTCCCCCACTGGTCCCATCTAGTGTTCCTCAGTGACGAAGGAG TGCTGAGCGGAATCTACTTCCTGTGCTCCTCGCTTCCACGTGCATCTTAAAGGTGTATTTAAACTGTTCTCAAACACTTCTTATACCTGGCAAAACCTTTATTATGTCTGGTCCAAACCCCCATGTGA AAGAACAAAGTGGTCTCCAAATTTCCAGGTCATTGCCTGGAGGGAGAGCTGACATCTACAGAAAAGTGTCCTCCTTGGAGACAGAGGCTCCTTGAAGGTGAATTTGCCTCATCAAAATCTGACTGCTC TCAGCAGCACAGGTCCATAGCTGGGAAAATCTACATACCCTGCCTACCAAGGTTGGCTTCTATGCCATGTGTGGCAGATGTCCTTGAAGGGGAAAGAAAATGATTTCTGTGTATAACTGCACACAAGG GGTATTTTGCCACAGTGGAAGTGTCCTAAACTAGCCTTATCTGATTGTCAAGCCTTGAAATGGGATTAGTGTGACTGGCGAAAGCCATAAACATTTCAAGACATCTTCAAATGGTCTCAAGTTACCGG TGACATCACATCATCTGAGTATCAGTTCCTCAAGAGGAATGGGCAGTCACTGTTGCCAAATCACTGGGCAGCGGCCAGTAACCTCAGACACCTTGTTGAAGGCATGCAACACGGAGCCTGGTAAAGAT ATTATCCAGGAGGAGGCCTAGCTTACACCTCACTTGTTAAAAGTTCACATTTGGGTCTAAGCATGGAACTGTAGTAGACCGCCTTCTTTGTCTATGTTGTGCCACCTCTTGAAGAGCAGCTCTGTTCT TATTAACTCAGCAGGCTTTTCTATCCACCTGTGAGCTAGGTTAATATGATGGGACCTCTTAAACACTTATGTGAGCCTCTAAGATACAGACCTACCACCCCACGTAACTCCTAAAGTAACATCCCACT AGGAGGCTGCTTACTAGTCTGGCTGTCTTTCTCCTATTTTATAGATGCTCTGACTAGGGTAGAGTAAGCGACATTCAGTCTGGTAAGTTAAACTTTTTTTATTCTAGCCTCAAGGCGGAAGCTGCTTT GTGCTTTGAACACTTGGCTTCCTTGCCCAAGCAGCTTGGTAGAGCATCAAAGATGACTTCCCCATCACACAGGGCTGGAAGTTTGTCCCTTTGTCCCTTTAATGCCTTACTATATAGTCACTTCAGCT TGCTGTCTGTACATTTCCCTTTGCAGAGGTTAGGCTGTATGTAGACCTTTGTATCTTTCCTGTCTTTCCACACAAGCCTAAGCATGACCTGAAACCCCCATCCCCCAAGGCTGGAAACATGCTCTCTG TGGCTTTTGTTTACACAATGCCAGTTGATGGCAGGCAGTGCTCATTATGGGATGCTCAACAGATCCGGCCATCAATAAGAGACAGGGTAGAATCCTTTCATCCAGCTCTCCCATAGGTGATACACTCC ACTCCACTCCCCTTAGGCACCTGGTCAGGTAGGTGGGTACAGGCCTGTGTCTACTCTGCAGTCTGCTCTTTAGGCTGGGCCAACCTTGGAGCCACACTTGTCTGTATCCAAACGCTACTGTCAGTGTT TTGGGGTAACTTGAAAACTTAACTGCCTACCTAGCTGTCTTGAGATTCCTTTCACTTAGCTCTTGAAGGCCCCTCTACAGTGGGACTGTAATAACTTCACACGGTGCTTGCCGTTTGCTCTTGAATCA CCCTTACACTTAGCTCCACGAGTAACTGTTCCACAATCCCATGTACTCTTGTGGATCTTGGCCAGGTCACAACACAGAGCATGTGGCCTGATGTCTGCCCACGTTTACAAGTGTTTTGGGAACCTCTG GTATCATCCCCCCACACCAGATGGAACAGGCATCTGTATTTAAACTTTATTACAAAATTATAAAGCAGAGCTCTGTAACAAAAAATACACATTTGGGTATGCTTACCACCCAGGTGAGAGAATCAATG TAAGCCACTTGGAGCTATACATTTATATCCAAGAGATCTCAAATGTGTACAACATAGACTATTAATTCCTTTACAGCTTGTTAGTTTAGAACCGGCTATTCCAACCAGTCAGCATCTTTGAAAACTAA GTCTCAACTAAAATCTTGGCGCAATCGGCAAAGTCCACAGAATAATTGGAAGGATTAGGTGTTTCCACATTAATTAAGACCAAGGATCCGTGAAGAACAGAAAAAGGGGCTCAGGTATTTAAAAAAAA AAATCAGTTTTTCTACCTGAGATATTAACTGGAATGAGTTCCAACTTCCATTTGGTTTAACAATAAAAAGGTTATTTGA
hide sequence
RefSeq Acc Id:
XM_039086028 ⟹ XP_038941956
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 10 68,217,248 - 68,238,705 (+) NCBI mRatBN7.2 10 67,719,677 - 67,741,141 (+) NCBI
RefSeq Acc Id:
XM_039086029 ⟹ XP_038941957
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 10 68,215,885 - 68,238,705 (+) NCBI mRatBN7.2 10 67,718,320 - 67,741,141 (+) NCBI
RefSeq Acc Id:
XM_039086030 ⟹ XP_038941958
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 10 68,215,886 - 68,238,705 (+) NCBI mRatBN7.2 10 67,718,537 - 67,741,141 (+) NCBI
RefSeq Acc Id:
XM_039086031 ⟹ XP_038941959
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 10 68,215,593 - 68,230,798 (+) NCBI mRatBN7.2 10 67,719,943 - 67,733,236 (+) NCBI
RefSeq Acc Id:
XM_063269079 ⟹ XP_063125149
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 10 68,215,604 - 68,238,705 (+) NCBI
RefSeq Acc Id:
XM_063269080 ⟹ XP_063125150
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 10 68,216,888 - 68,238,705 (+) NCBI
RefSeq Acc Id:
XM_063269081 ⟹ XP_063125151
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 10 68,215,601 - 68,235,180 (+) NCBI
RefSeq Acc Id:
XM_063269082 ⟹ XP_063125152
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 10 68,217,510 - 68,238,705 (+) NCBI
RefSeq Acc Id:
XM_063269083 ⟹ XP_063125153
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 10 68,215,600 - 68,235,180 (+) NCBI
RefSeq Acc Id:
XP_008766243 ⟸ XM_008768021
- Peptide Label:
isoform X4
- UniProtKB:
A0A096MKE9 (UniProtKB/TrEMBL)
- Sequence:
MTLAFKTLFPRNLCALGRKELCLFSEQHHWPAIRQFSQWSETNLLCGCCLLQRRKPVLSFQRGHLRPRATHLISWSGSHVGLCTGPCEMAEQRFCVDYAKRGTAGCKKCKEKIVKGVCRIGKVVPNPF SESGGDMKEWYHIKCMFEKLERARATTKKIEDLTELEGWEELEDNEKEQISQHIADLSSKTAATPKKKATVQAKLTTTGQVTSPVKGASFITSTNPRKFSGFSAAKPNNSEQDPSSPAPKTSLSASKC DPKHKDCLLREFRKLCAMVAENPSYNTKTQIIHDFLQKGSTGDGFRGDVYLTVKLLLPGVIKSVYNLNDKQIVKLFSRIFNCNPDDMARDLEQGDVSETIRVFFEQSKSFPPAAKSLLTIQEVDAFLL HLSKLTKEDEQQQALQDIASRCTANDLKCIIRLIKHDLKMNSGAKHVLDALDPNAYEAFKASRNLQDVVERVLHNEQEVEKDPGRRRALSVQASLMTPVQPMLAEACKSIEYAMKKCPNGMFSEIKYD GERVQVHKKGDHFSYFSRSLKPVLPHKVAHFKDYIPKAFPGGQSMILDSEVLLIDNNTGKPLPFGTLGVHKKAAFQDANVCLFVFDCIYFNDVSLMDRPLCERRKFLHDNMVEIRNRIMFSEMKQVTK ASDLADMINRVIREGLEGLVLKDVKGTYEPGKRHWLKVKKDYLNEGAMADTADLVVLGAFYGQGSKGGMMSIFLMGCYDPDSQKWCTVTKCAGGHDDATLARLQKELDMVKISKDPSKIPSWLKINKI YYPDFIVPDPKKAAVWEITGAEFSRSEAHTADGISIRFPRCTRIRDDKDWKSATNLPQLKELYQLSKDKADFAVVAGDEGSSTTGGSNGEKLAVKSSPVKVGMKRKAADETPGLTKALLDVFTGVRLY LPPSTPDFRRLKRYFVAFNGDLVQEFDMASATHVLGNRDKNTDAQLVSSEWIWACIRKRRLVAPC
hide sequence
RefSeq Acc Id:
XP_008766242 ⟸ XM_008768020
- Peptide Label:
isoform X2
- UniProtKB:
A0A0G2JV76 (UniProtKB/TrEMBL), A6HHE1 (UniProtKB/TrEMBL)
- Sequence:
MTLAFKTLFPRNLCALGRKELCLFSEQHHWPAIRQFSQWSETNLLCGCCLLQRRKPVLSFQRGHLRPRATHLISWSGSHVGLCTGPCEMAEQRFCVDYAKRGTAGCKKCKEKIVKGVCRIGKVVPNPF SESGGDMKEWYHIKCMFEKLERARATTKKIEDLTELEGWEELEDNEKEQISQHIADLSSKTAATPKKKATVQAKLTTTGQVTSPVKGASFITSTNPRKFSGFSAKPNNSEQDPSSPAPKTSLSASKCD PKHKDCLLREFRKLCAMVAENPSYNTKTQIIHDFLQKGSTGDGFRGDVYLTVKLLLPGVIKSVYNLNDKQIVKLFSRIFNCNPDDMARDLEQGDVSETIRVFFEQSKSFPPAAKSLLTIQEVDAFLLH LSKLTKEDEQQQALQDIASRCTANDLKCIIRLIKHDLKMNSGAKHVLDALDPNAYEAFKASRNLQDVVERVLHNEQEVEKDPGRRRALSVQASLMTPVQPMLAEACKSIEYAMKKCPNGMFSEIKYDG ERVQVHKKGDHFSYFSRSLKPVLPHKVAHFKDYIPKAFPGGQSMILDSEVLLIDNNTGKPLPFGTLGVHKKAAFQDANVCLFVFDCIYFNDVSLMDRPLCERRKFLHDNMVEIRNRIMFSEMKQVTKA SDLADMINRVIREGLEGLVLKDVKGTYEPGKRHWLKVKKDYLNEGAMADTADLVVLGAFYGQGSKGGMMSIFLMGCYDPDSQKWCTVTKCAGGHDDATLARLQKELDMVKISKDPSKIPSWLKINKIY YPDFIVPDPKKAAVWEITGAEFSRSEAHTADGISIRFPRCTRIRDDKDWKSATNLPQLKELYQLSKDKADFAVVAGDEGSSTTGGSNGENEGTAGSTVPRKGPKGPPSKSSASAKKTEQKLNDPSSRG GEKLAVKSSPVKVGMKRKAADETPGLTKALLDVFTGVRLYLPPSTPDFRRLKRYFVAFNGDLVQEFDMASATHVLGNRDKNTDAQLVSSEWIWACIRKRRLVAPC
hide sequence
Ensembl Acc Id:
ENSRNOP00000052836 ⟸ ENSRNOT00000055982
Ensembl Acc Id:
ENSRNOP00000069379 ⟸ ENSRNOT00000084076
Ensembl Acc Id:
ENSRNOP00000068489 ⟸ ENSRNOT00000076739
Ensembl Acc Id:
ENSRNOP00000068142 ⟸ ENSRNOT00000076703
RefSeq Acc Id:
XP_038941957 ⟸ XM_039086029
- Peptide Label:
isoform X3
- UniProtKB:
A0A0G2JV76 (UniProtKB/TrEMBL), A6HHE1 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_038941958 ⟸ XM_039086030
- Peptide Label:
isoform X3
- UniProtKB:
A0A0G2JV76 (UniProtKB/TrEMBL), A6HHE1 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_038941956 ⟸ XM_039086028
- Peptide Label:
isoform X3
- UniProtKB:
A0A0G2JV76 (UniProtKB/TrEMBL), A6HHE1 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_038941959 ⟸ XM_039086031
- Peptide Label:
isoform X8
RefSeq Acc Id:
NP_001380965 ⟸ NM_001394036
- Peptide Label:
isoform 1
- UniProtKB:
A0A0G2JV76 (UniProtKB/TrEMBL), A6HHE1 (UniProtKB/TrEMBL)
RefSeq Acc Id:
NP_001380964 ⟸ NM_001394035
- Peptide Label:
isoform 1
- UniProtKB:
A0A0G2JV76 (UniProtKB/TrEMBL), A6HHE1 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063125153 ⟸ XM_063269083
- Peptide Label:
isoform X7
- UniProtKB:
Q5U2M4 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063125151 ⟸ XM_063269081
- Peptide Label:
isoform X5
- UniProtKB:
Q5U2M4 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063125149 ⟸ XM_063269079
- Peptide Label:
isoform X1
- UniProtKB:
A0A0G2JV76 (UniProtKB/TrEMBL), A6HHE1 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063125150 ⟸ XM_063269080
- Peptide Label:
isoform X3
- UniProtKB:
A0A0G2JV76 (UniProtKB/TrEMBL), A6HHE1 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063125152 ⟸ XM_063269082
- Peptide Label:
isoform X6
- UniProtKB:
Q5U2M4 (UniProtKB/TrEMBL)
RGD ID: 13697515
Promoter ID: EPDNEW_R8039
Type: initiation region
Name: Lig3_1
Description: DNA ligase 3
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Experiment Methods: Single-end sequencing.
Position: Rat Assembly Chr Position (strand) Source Rnor_6.0 10 70,134,766 - 70,134,826 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2016-05-04
Lig3
DNA ligase 3
Lig3
ligase III, DNA, ATP-dependent
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2005-12-06
Lig3
ligase III, DNA, ATP-dependent
Lig3_predicted
ligase III, DNA, ATP-dependent (predicted)
Symbol and Name updated
1559027
APPROVED
2005-01-12
Lig3_predicted
ligase III, DNA, ATP-dependent (predicted)
Symbol and Name status set to approved
70820
APPROVED